2,564
Views
37
CrossRef citations to date
0
Altmetric
Research Article

Controlled-release carbamazepine matrix granules and tablets comprising lipophilic and hydrophilic components

, &
Pages 57-65 | Received 13 Jun 2008, Accepted 18 Aug 2008, Published online: 01 Jan 2009

References

  • Aïnaoui A, Vergnaud JM 2000. Effect of the nature of the polymer and of the process of drug release (diffusion or erosion) for oral dosage forms. Comput. Theor. Pol. Sci. 10, 383–390.
  • Akbari J, Adrangr M, Farid D, Siahi-shadbad MR, Saeedi M, Nokhodchi A 2000. The effect of various factors on the release rate of poorly soluble drug (carbamazepine) from hydroxypropylmethylcellulose matrices. STP Pharma. Sci. 10, 473–478.
  • Alderman DA 1984. A review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms. Int. J. Pharm. Tech. Prod. Manuf. 5, 1–9.
  • Barakat NS, Elbagory IM, Almurshedi AS 2008. Formulation, release characteristics and bioavailability study of oral monolithic matrix tablets containing carbamazepine. AAPS Pharm. Sci. Tech. (published online http://www.aapspharmscitech.org).
  • Efentakis M., Vlachou M, Choulis NH 1997. Effects of excipients on swelling and drug release from compressed matrices. Drug Dev. Ind. Pharm. 23, 107–112.
  • Gao P, Skoug JW, Nixon PR, Ju TR, Stemm NL, Sung K-C 1996. Swelling of hydroxypropylmethylcellulose matrix tablets. 2. Mechanistic study of the influence of formulation variables on matrix performance and drug release. J. Pharm. Sci. 85, 732–740.
  • Graham NB, McNeill ME 1984. Hydrogels for controlled drug delivery. Biomaterials 5, 27–36.
  • Heller J, Helwing RF, Baker RW, Tutte ME 1983. Controlled release of water-soluble macromolecules from bioerodible hydrogels. Biomaterials 4, 262–266.
  • Huang X, Brazel CS 2001. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J. Control. Rel. 73, 121–136.
  • Khan KA 1975. The concept of dissolution efficiency. J. Pharm. Pharmacol. 27, 48–49.
  • Khurahashi H, Kami H, Sunada H 1996. Influence of physicochemical properties on drug release rate from hydroxypropyl methylcellulose matrices. Chem. Pharm. Bull. 44, 829–832.
  • Kiortsis S, Kachrimanis K, Broussali Th, Malamataris S 2005. Drug release from tableted wet granulations comprising cellulosic (HPMC or HPC) and hydrophobic component. Eur. J. Pharm. Biopharm. 59, 73–83.
  • Korsmeyer RW, Gurny R, Doelker EM, Buri P, Peppas NA 1983. Mechanism of release from porous hydrophilic polymers. Int. J. Pharm. 15, 25–35.
  • Kudela V 1987. Hydrogels, In, Encyclopedia of Polymer Science and Engineering, ed. Herman, F.Mark, Vol. 7, pp. 703–807. New York; Wiley.
  • Lotfipour F, Nokhodchi A, Saeedi M, Norouzi-Sani S, Sharbafi J, Siahi-Shadbad MR 2004. The effect of hydrophilic and lipophilic polymers and fillers on the release rate of atenolol from HPMC matrices. IL Farmaco 59, 819–825.
  • Lowman AM, Peppas NA 2000. Hydrogels. In, Encyclopedia of Controlled Drug Delivery, ed. Mathiowitz E, pp. 397–417. New York: John Wiley and Sons, Inc.
  • Malamataris S, Ganderton D 1991. Sustained release from matrix systems comprising hydrophobic and hydrophilic (gel-forming) parts. Int. J. Pharm. 70, 69–75.
  • Moore JW, Flanner HH 1996. Mathematical comparison of curves with an emphasis on in vitro dissolution profiles. Pharm. Technol. 20, 64–74.
  • Peppas NA, Sahlin JJ 1989. A simple equation for the descripition of solute release: III. Coupling of diffusion and relaxation. Int. J. Pharm. 57, 169–172.
  • Peppas NA, Simmons REP 2004. Mechanistic analysis of protein delivery from porous poly (vinyl alcohol) systems. J. Drug Del. Sci. Tech. 14, 285–289.
  • Rajabi-Siahboomi AR, Bowtell RW, Mansfield P, Henderson A, Davies MC, Melia CD 1994. Structure and behavior in hydrophilic matrix sustained release and dosage forms: 2. NMR-imaging studies of dimensional changes in the gel layer and core of HPMC tablets undergoing hydration. J. Control. Rel. 31, 121–128.
  • Rekhi GS, Nellore RV, Hussain AS, Tillman LG, Malinowski HJ, Augsburger LL 1999. Identification of critical formulation and processing variables for metoprolol tartrate extended-release (ER) matrix tablets. J. Control. Rel. 59, 327–342.
  • Roy DS, Rohera BD 2002. Comparative evaluation of rate of hydration and matrix erosion of HEC and HPC and study of drug release from their matrices. Eur. J. Pharm. Sci. 16, 193–199.
  • Skoug JW, Mikelsons MV, Vigneron CN, Stemm NL 1993. Qualitative evaluation of the mechanism of release of matrix sustained release dosage forms by measurement of polymer release. J. Control. Rel. 27, 227–245.
  • Sutananata W, Craig DQM, Newton JM 1995a. An evaluation of the mechanism of drug release from glyceride bases. J. Pharm. Pharmacol. 47, 182–187.
  • Sutananata W, Craig DQM, Newton JM 1995b. An investigation into the effects of preparation conditions and storage on the rate of drug release from pharmaceutical glycerides bases. J. Pharm. Pharmacol. 47, 355–359.
  • Voegele D, Brockmeier D, Von Hattingberg HM, Lippold BC 1983. Die mittlere Auflösezeit—ein parameter zur prüfung von liberationsbedingungen auf vergleichbarkeit. Acta Pharm. Techno. 29, 167–174.
  • Wan LSC, Heng PWS, Wong LF 1993. Relationship between swelling and drug release in a hydrophilic matrix. Drug Dev. Ind. Pharm. 19, 1201–1210.
  • Wells JI 1997. Tablet testing. In, Encyclopedia of Pharmaceutical Technology, Vol. 14, eds. Swarbrick J, Boylan JC, pp. 401–418. New York: Marcel Dekker.
  • Zuleger S, Lippold BC 2001. Polymer particles erosion controlling drug release. I. Factors influencing drug release and characterization of the release mechanism. Int. J. Pharm. 217, 139–152.